Search results
Author(s):
Angelo Auricchio
,
François Regoli
,
Giulio Conte
,
et al
Added:
3 years ago
The number of cardiovascular implantable electronic devices (CIEDs) has increased progressively during the past decades, with a parallel increase in the demand for transvenous lead extraction (TLE). Indication and class of recommendation for TLE have been extensively discussed in a recent expert consensus document.1 With the exception of a few prospectively conducted registries,2,3 the vast…
View more
Ep. 5: Procedure of Lead Extraction
Added:
1 year ago
Podcast Episode
Author(s):
Roger Carillo
Added:
5 years ago
Roger Carillo (University of Miami Hospital, Miami, US) discusses the multi-year evaluation of compliant endovascular balloon in treating superior vena cava tears during transvenous lead extraction at EHRA 2018.
Filmed by Radcliffe Cardiology on-site at EHRA 2018.
View more
Author(s):
Adryan A Perez
,
Frank W Woo
,
Darren C Tsang
,
et al
Added:
3 years ago
The use of cardiovascular implantable electronic devices (CIEDs) has increased dramatically, with approximately 1.2–1.4 million CIEDs implanted annually worldwide.1 In the US alone, there are more patients with CIEDs than registered nurses.2,3 CIEDs use leads that connect a generator to cardiac tissue to treat patients with many conditions including symptomatic bradycardia, morbid tachycardia…
View more
Optimal Management of CIED Infections
Video Series
Optimal Management of CIED Infections
Added:
1 year ago
Podcast Series
Author(s):
Khaldoun G Tarakji
,
Christopher R Ellis
,
Pascal Defaye
,
et al
Added:
3 years ago
Over the last few decades an increasing body of evidence has supported the role of cardiovascular implantable electronic devices (CIEDs) including permanent pacemakers (PPMs), implantable cardioverter-defibrillators (ICDs) and cardiac resynchronisation therapy (CRT-D [with defibrillator] and CRT-P [without defibrillator]) in improving quality of life and survival.1 In addition, there has been a…
View more
Author(s):
Rikke Esberg Kirkfeldt
,
Jens Brock Johansen
,
Jens Cosedis Nielsen
Added:
3 years ago
Cardiac implantable electronic device (CIED) therapy is effective and safe. However, infections related to CIED treatment may have devastating consequences, causing significant morbidity, mortality and generating considerable healthcare costs.1–6 Temporal trends in CIED treatment indicate a disproportional increase in CIED infections relative to implantation rates.1,7,8 Reasons for this trend are…
View more
Harish Manyam
Job title: Chief of Cardiology, Director of Cardiovascular Research and Head of the Atrial Fibrillation Center
Author
Author(s):
Niek EG Beurskens
,
Fleur VY Tjong
,
Reinoud Knops
Added:
3 years ago
Since its introduction in 2012, leadless pacemaker (LP) therapy has developed as a therapeutic alternative to conventional transvenous pacemaker (PM) therapy to circumvent lead- and pocket-related complications.1-4 To date, two LPs are available for patients with a single-chamber pacing (VVI) indication: the Nanostim Leadless Cardiac Pacemaker (LCP; Abbott) and the Micra Transcatheter Pacing…
View more